Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05855837 · ClinicalTrials.gov registry record · NA
Appetite Responses to Cereal Products
A NA study, sponsored by General Mills.
- Completed
- Registry status
- NA
- Development phase
- 228
- Enrollment target
NCT05855837: Completed NA study, sponsored by General Mills.
NCT05855837 is a NA study that has completed, run by General Mills. The registered enrollment target is 228 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05855837, a NA study, has completed, sponsored by General Mills.
- COMPLETED
- Registry status
- NA
- Development phase
- 228 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to investigate appetite responses to 2 cereal products in healthy adults.
Primary Outcome
Visual Analogue Scale for "how hungry are you right now?" is scored from 0-100 millimeters (mm), whereby a higher mm indicates more hunger. Comparing change from 0 minutes (baseline) to 240 minutes, whereby a lower mm change from baseline indicates a better outcome.
Interventions
- OTHER Ready to Eat Cereal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2023-06-05 |
| Est. Completion | 2023-08-30 |
| Phase | NA |
What the finished NCT05855837 record still lists
NCT05855837 is an interventional study that assigns participants to a tested intervention. The registered 228 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 1 intervention - of which Ready to Eat Cereal is the first listed.
NCT05855837 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05855837 about?
NCT05855837 is a clinical study titled "Appetite Responses to Cereal Products". The purpose of this clinical trial is to investigate appetite responses to 2 cereal products in healthy adults.
What is the current status of trial NCT05855837?
This trial is currently completed. It is a NA study. The enrollment target is 228 participants. The study started on 2023-06-05. Estimated completion is 2023-08-30.
What interventions are being tested in trial NCT05855837?
The interventions under investigation include: Ready to Eat Cereal (OTHER).
Who is sponsoring clinical trial NCT05855837?
This trial is sponsored by General Mills, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05855837's enrollment target sits among peer trials
228 468th of 2000 higher than 1,530 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05107908 · 228 participants · NA
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
- NCT05547698 · 228 participants · NA
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
- NCT05630963 · 228 participants
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
- NCT06073665 · 228 participants · Phase 4
Dosing of LT4 in Older Individuals
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI